Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2002 R21 PAR-01-104 YEUNG, EDWARD S. IOWA STATE UNIVERSITY SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING Complete
1999 R21 PAR-98-067 VIDAL, MARC MASSACHUSETTS GENERAL HOSPITAL NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING Complete
2007 R21 RFA-CA-07-002 GARRAWAY, LEVI ALEXANDER DANA-FARBER CANCER INST HIGH-THROUGHPUT ONCOGENE MUTATION DETECTION IN HUMAN CANCER Complete
2017 R21 RFA-CA-16-001 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA A Target-Directed Reagent Pipeline via Microfluidic mRNA Display Complete
2006 R21 RFA-CA-06-004 HSI, ERIC CLEVELAND CLINIC LERNER COL/MED-CWRU CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 MC GOWN, LINDA B. RENSSELAER POLYTECHNIC INSTITUTE HYBRIDIZATION OF PROMOTER DNA TARGETS IN CHROMATIN TO DISCOVER REGULATORY PROTEIN Complete
2013 R21 RFA-CA-12-002 CASTRO, CARLOS E. OHIO STATE UNIVERSITY NANOSCALE TOOLS FOR FUNCTIONAL STUDIES OF CANCER-RELEVANT CHROMATIN MODIFICATIONS Complete
2016 R21 RFA-CA-15-002 SADEGHI , SAMAN UNIVERSITY OF CALIFORNIA LOS ANGELES ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2011 R21 RFA-CA-10-005 HUANG, SONGPING D KENT STATE UNIVERSITY AT KENT PRUSSIAN BLUE NANOPARTICLES AS CELLULAR T1 MRI CONTRAST AGENTS Complete
2022 R21 CA21-003 KELLY, RYAN T BRIGHAM YOUNG UNIVERSITY In-depth and label-free proteome profiling of hundreds of single cells per day Active
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 WYMAN, ROBERT J YALE UNIVERSITY GENETIC METHODS FOR DETECTING GAP JUNCTION COMMUNICATION Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2007 R21 RFA-CA-07-002 SEGALL, JEFFREY E ALBERT EINSTEIN COLLEGE OF MEDICINE DEVELOPMENT OF AN IN VIVO METASTASIS SCREEN Complete
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing NCE
2020 R21 RFA-CA-19-019 SHVETS, GENNADY CORNELL UNIVERSITY Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces Active
2006 R21 RFA-CA-06-004 COTE, RICHARD JAMES UNIVERSITY OF SOUTHERN CALIFORNIA INTEGRATED MICRODEVICE TO CAPTURE AND DETECT CIRCULATING TUMOR CELLS Complete
2009 R21 RFA-CA-08-006 CHAREST, JOSEPH LEO CHARLES STARK DRAPER LABORATORY MICROFLUIDIC 3D SCAFFOLD ASSAY FOR CANCER CELL MIGRATION AND INTRAVASATION Complete
2013 R21 RFA-CA-12-002 BAI, MINGFENG UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND TREATMENT MONITORING Complete
2016 R21 RFA-CA-15-002 SEGAL, DAVID J UNIVERSITY OF CALIFORNIA AT DAVIS CRISPR-BASED EPIGENETIC MODIFIERS Complete

Pages